Project Number 2R44AG058343-04 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) l. Growth Factors and Hormones Researcher and Organization Principal Investigator VITALIANO, FRANCO Principal Investigator First Name FRANCO Principal Investigator Last Name VITALIANO Awardee Organization EXQOR TECHNOLOGIES, INC. Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $1,006,687 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
